FGFR3 Stimulates Stearoyl CoA Desaturase 1 Activity to Promote Bladder Tumor Growth

作者: Xiangnan Du , Qian-Rena Wang , Emily Chan , Mark Merchant , Jinfeng Liu

DOI: 10.1158/0008-5472.CAN-12-1329

关键词:

摘要: Fibroblast growth factor receptor 3 (FGFR3) belongs to a family of tyrosine kinases that control cell proliferation, differentiation, and survival. Aberrant activation FGFR3 via overexpression or mutation is frequent feature bladder cancer; however, its molecular cellular consequences functional relevance carcinogenesis are not well understood. Through transcriptional profiling carcinoma cells subjected short hairpin RNA knockdown FGFR3, we identified gene-signature linking signaling with de novo sterol lipid biosynthesis metabolism. We found promotes the cleavage master regulator lipogenesis, regulatory element-binding protein 1(SREBP1/SREBF1), in PI3K-mTORC1-dependent fashion. In turn, SREBP1 regulates expression key lipogenic enzymes, including stearoyl CoA desaturase 1 (SCD1/SCD). SCD1 rate-limiting enzyme monounsaturated fatty acids crucial for homeostasis. human cancer lines expressing constitutively active by siRNA markedly attenuated cell-cycle progression, reduced induced apoptosis. Furthermore, inducible xenograft model substantially inhibited tumor progression. Pharmacologic inhibition blocked acid desaturation also exerted antitumor activity vitro vivo. Together, these findings reveal previously unrecognized role regulating metabolism maintain survival, identify as potential therapeutic target FGFR3-driven cancer.

参考文章(50)
Chandan Kumar-Sinha, Arul M. Chinnaiyan, Marc E. Lippman, Kathleen Woods Ignatoski, Stephen P. Ethier, Transcriptome Analysis of HER2 Reveals a Molecular Connection to Fatty Acid Synthesis Cancer Research. ,vol. 63, pp. 132- 139 ,(2003)
David Cappellen, Catherine De Oliveira, David Ricol, Sixtina de Medina, Jérôme Bourdin, Xavier Sastre-Garau, Dominique Chopin, Jean Paul Thiery, François Radvanyi, Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nature Genetics. ,vol. 23, pp. 18- 20 ,(1999) , 10.1038/12615
Margaret A Knowles, None, Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors Future Oncology. ,vol. 4, pp. 71- 83 ,(2008) , 10.2217/14796694.4.1.71
Kazuko Kuroso, Yasuo Imai, Masashi Kobayashi, Kunio Yanagimoto, Tsukasa Suzuki, Masato Kojima, Yoshihiko Ueda, Immunohistochemical Detection of Fibroblast Growth Factor Receptor 3 in Human Breast Cancer: Correlation with Clinicopathological/Molecular Parameters and Prognosis Pathobiology. ,vol. 77, pp. 231- 240 ,(2010) , 10.1159/000314346
Anne Goriely, Ruth M S Hansen, Indira B Taylor, Inge A Olesen, Grete Krag Jacobsen, Simon J McGowan, Susanne P Pfeifer, Gilean A T McVean, Ewa Rajpert-De Meyts, Andrew O M Wilkie, Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors Nature Genetics. ,vol. 41, pp. 1247- 1252 ,(2009) , 10.1038/NG.470
Katrin Düvel, Jessica L. Yecies, Suchithra Menon, Pichai Raman, Alex I. Lipovsky, Amanda L. Souza, Ellen Triantafellow, Qicheng Ma, Regina Gorski, Stephen Cleaver, Matthew G. Vander Heiden, Jeffrey P. MacKeigan, Peter M. Finan, Clary B. Clish, Leon O. Murphy, Brendan D. Manning, Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1 Molecular Cell. ,vol. 39, pp. 171- 183 ,(2010) , 10.1016/J.MOLCEL.2010.06.022
Hikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, Oscar Lin, Adriana Heguy, Satish K. Tickoo, Samson W. Fine, Anuradha Gopalan, Ying-bei Chen, Arjun Balar, Jamie Riches, Bernard Bochner, Guido Dalbagni, Dean F. Bajorin, Victor E. Reuter, Matthew I. Milowsky, David B. Solit, Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma. The Journal of Pathology. ,vol. 224, pp. 270- 279 ,(2011) , 10.1002/PATH.2892
DC Tomlinson, O Baldo, P Harnden, MA Knowles, FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer The Journal of Pathology. ,vol. 213, pp. 91- 98 ,(2007) , 10.1002/PATH.2207
Yu-An Yang, Wan Fang Han, Patrice J Morin, Francis J Chrest, Ellen S Pizer, Activation of Fatty Acid Synthesis during Neoplastic Transformation: Role of Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Experimental Cell Research. ,vol. 279, pp. 80- 90 ,(2002) , 10.1006/EXCR.2002.5600
Nicholas Turner, Richard Grose, Fibroblast growth factor signalling: from development to cancer. Nature Reviews Cancer. ,vol. 10, pp. 116- 129 ,(2010) , 10.1038/NRC2780